September 2007 Oncology News International

Publication
Article

Focus on Breast Cancer

ASCO studies pose question: Do brain metastases in patients with HER2+ breast ca affect overall survival?

Focus on Lung Cancer

Some long-term stablization in NSCLC with enzastaurin

Diagnostic Dilemma

Diagnostic Dilemma: GI Disease

Focus on Oncology Nursing

Nurses can administer rituximab safely by rapid infusion

Monitoring essential for heading off retinoic acid syndrome

Focus on Hematology

WT1 peptide vaccine produces durable disease control in some patients with AML or MDS; a phase II study is on the horizon

New proteasome inhibitor tested in relapsed/refractory myeloma

Phase II trial to evaluate four-drug therapy in myeloma

Focus on Colon Cancer

Loss of two hormones creates a 'recipe for colon cancer'

African Americans with proximal polyps and overweight or obese women are at higher risk for colorectal cancer: Researchers call for more screening

5T4 vaccine appears promising in metastatic colorectal ca

Focus on Prostate Cancer

Single PSA at midlife predicts advanced prostate ca risk

Cancer Care & Economics

The breast cancer HDCT/transplant debacle: Why did it happen, and could it happen again?

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content